ArticleDrug design, development and therapy2017
Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs.
Yuren Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it